Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue
July 14, 2026 4:03 PM EDTKestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($0.67), $0.09 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $28.64 million, versus $26.5 million reported last year.
For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.
... More


